measurable residualdisease testing in acutelymphoblastic leukemia: testing, sampling, and guidelines
Published 1 year ago • 265 plays • Length 1:05:11Download video MP4
Download video MP3
Similar videos
-
1:01:40
measurable residual disease by multiparametric flow cytometry in acute lymphoblastic leukemia
-
1:15
measurable residual disease testing in acute lymphoblastic leukemia| free webinar| pathology hub
-
4:35
learn about measurable residual disease (mrd)
-
3:10
measurable residual disease - what tests used, how do they work, and which is best for the patient
-
8:53
all: when and who to test for minimal residual disease
-
2:35
mrd focus: why measurable residual disease testing is the future
-
22:56
measurable residual disease (mrd) in aml and all
-
4:50
importance of mrd testing in acute lymphoblastic leukemia
-
2:51
mrd testing in acute leukemias
-
1:02
challenges with measurable residual disease (mrd) assessment in acute myeloid leukemia (aml)
-
7:24
a conversation on mrd in all
-
52:40
measurable residual disease
-
4:20
an overview of minimal residual disease testing
-
1:23
measurable residual disease - when should they test mrd and how do they get mrd from patients
-
26:07
prof. maurice o'gorman - b acute lymphoblastic leukaemia minimal residual disease testing
-
4:58
role of mrd testing in adult acute lymphocytic leukemia
-
6:20
mrd testing in all: sensitivity and availability
-
7:13
strategies to assess minimal residual disease
-
9:03
iccs education: minimal/measurable residual disease testing (mrd) by flow cytometry in bll